Become a Client
Fidelity Funds - Global Health Care Fund A-Acc-EUR
Fidelity Funds (SICAV domiciled in Luxembourg)
Key Information
Legal Documents

Fund Profile

Category: SICAV

Key Investor Information This document provides you with key investor information about this fund. It is not marketing material. The information is required by law to help you understand the nature and the risks of investing in this fund. You are advised to read it so you can make an informed decision about whether to invest. Fidelity Funds - Global Health Care Fund a sub-fund of Fidelity Funds A-ACC-Euro (ISIN: LU0261952419) This fund is managed by FIL Investment Management (Luxembourg) S.A. n The fund aims to provide long-term capital growth with the level of income expected to be low. n At least 70% invested in the shares of companies throughout the world that are involved in the design, manufacture, or sale of products and services used in health care, medicine or biotechnology. n The fund has the freedom to invest outside its principal geographies, market sectors, industries or asset classes. n As this fund may invest globally, it may invest in countries considered to be emerging markets. n The fund may invest in assets directly or achieve exposure indirectly through other eligible means including derivatives. The fund can use derivatives with the aim of risk or cost reduction or to generate additional capital or income, including for investment purposes, in line with the fund’s risk profile. n The fund is actively managed. The Investment Manager will, when selecting investments for the fund and for the purposes of monitoring risk, reference MSCI ACWI Health Care Index (Net) (the ‘‘Index’’).The fund’s performance can be assessed against its Index. The Investment Manager has a wide range of discretion relative to the Index. While the fund will hold assets that are components of the Index, it may also invest in companies, countries or sectors that are not included in, and that have different weightings from, the Index in order to take advantage of investment opportunities. n Income earned by the fund is accumulated in the share price. n Shares can usually be bought and sold each business day of the fund. Lower risk Higher risk Typically lower rewards Typically higher rewards 1 2 3 4 5 6 7 n Historical data may not be a reliable indication for the future. n The risk category shown is not guaranteed and may change over time. n The lowest category does not mean a "risk free" investment. n The

Morningstar Rating
More information about the calculation of the Morningstar Ratings
Risk and reward profile
Lower Risk
Possible Lower
Higher Risk
Possible Higher
Key Information
Closing Price 24/06/202139.37
Morningstar categorySector Equity Healthcare
Distribution statusAccumulating
Inception Date25/09/2006
Minimum initial amount100.00 EUR
Fees And Charges
Entry feeNone
Custody feeNone
Exit feeNone
Ongoing charge1.91% of which 0.60% is paid to MeDirect
Fund management company
AddressFidelity (FIL Inv Mgmt (Lux) S.A.) 2a, rue Albert Borschette Luxembourg L-1246 Luxembourg
Manager NameAlex Gold
Manager Start Date01/07/2019
Total Net Assets (mil)1,322.08 EUR (31/05/2021)
AdministratorFIL Investment Management (Lux) S.A


en 01/01/2021
Annual Report
en 30/04/2020
Semi Annual Report
en 31/10/2020
Morningstar Report


Historical returns are no guarantee for future performances. Investing in Financial markets and securities involves risk. Past performance is not a guarantee of future results. Investment losses may occur and investors could lose some or all of their investment in the Fund.
Entry fees, purchase charges, custody fees, exit fees, sale charges and taxes are not included in the calculation of past performance. Ongoing charges (including management fees, administrative fees and other costs) have been taken in to account, as they are already included in the price/NAV of the fund.
Annualised performance in EUR
PeriodAnnualised returnDate
1 year23.92%24/06/2021
3 years14.80%24/06/2021
5 years11.44%24/06/2021
10 years13.95%24/06/2021
Since launch9.74%24/06/2021
Cumulative performance in EUR
YTD 01/01/202117.03
1 month4.79
3 months11.85
6 months17.70
Quarterly Returns
Q 1Q 2Q 3Q 4


Asset Allocation
% Long% Short% Net Assets
Return/Risk Analysis
Risk Measurement1 Year3 Years5 Years
Standard Deviation
Sharpe Ratio
Sortino Ratio
Positive Months7.0025.0037.00
Negative Months5.0011.0023.00
Worst Month-2.74-7.25-7.25
World Regions
United States68.26
Europe - ex Euro9.39
United Kingdom6.92
Asia - Emerging2.01
Latin America0.54
Middle East0.19
Stock Sector Weighting
Sector% of Equity
Consumer Cyclical
Top 10 Holdings
HoldingSectorCountry% of Assets
UnitedHealth Group Inc HealthcareUnited States5.87
Thermo Fisher Scientific Inc HealthcareUnited States5.43
IQVIA Holdings Inc HealthcareUnited States4.07
Danaher Corp HealthcareUnited States3.83
AstraZeneca PLC HealthcareUnited Kingdom3.70
Roche Holding AG HealthcareSwitzerland3.70
Stryker Corp HealthcareUnited States3.35
Cigna Corp HealthcareUnited States2.90
Humana Inc HealthcareUnited States2.90
Eli Lilly and Co HealthcareUnited States2.76
Classification of Morningstar Category
Ranking1 Year2 Years3 Years5 Years
Top 25%
Category above the average
Category below the average
Bottom 25%
Morningstar Style Box
Equity Style
Closing Price
All key information and documents must be reviewed before being able to Invest.

© 2021 MeDirect Bank (Malta) plc. All rights reserved.
MeDirect Bank (Malta) plc, company registration number C34125, is licensed to undertake the business of banking in terms of the Banking Act (Cap. 371) and investment services under the Investment Services Act (Cap. 370). MeDirect Bank (Malta) plc is regulated by the Malta Financial Services Authority as a Credit Institution under the Banking Act 1994.